Suppr超能文献

监测抗逆转录病毒治疗项目的扩大规模:估计覆盖率的方法。

Monitoring the scale-up of antiretroviral therapy programmes: methods to estimate coverage.

作者信息

Boerma J Ties, Stanecki Karen A, Newell Marie-Louise, Luo Chewe, Beusenberg Michel, Garnett Geoff P, Little Kirsty, Calleja Jesus Garcia, Crowley Siobhan, Kim Jim Yong, Zaniewski Elizabeth, Walker Neff, Stover John, Ghys Peter D

机构信息

The World Health Organization, Geneva, Switzerland.

出版信息

Bull World Health Organ. 2006 Feb;84(2):145-50. doi: 10.2471/blt.05.025189. Epub 2006 Feb 23.

Abstract

This paper reviews the data sources and methods used to estimate the number of people on, and coverage of, antiretroviral therapy (ART) programmes in low- and middle-income countries and to monitor the progress towards the "3 by 5" target set by WHO and UNAIDS. We include a review of the data sources used to estimate the coverage of ART programmes as well as the efforts made to avoid double counting and over-reporting. The methods used to estimate the number of people in need of ART are described and expanded with estimates of treatment needs for children, both for ART and for cotrimoxazole prophylaxis. An estimated 6.5 million people were in need of treatment in low- and middle-income countries by the end of 2004, including 660,000 children under age 15 years. The mid-2005 estimate of 970,000 people receiving ART in low- and middle-income countries (with an uncertainty range 840,000-1,100,000) corresponds to a coverage of 15% of people in need of treatment.

摘要

本文回顾了用于估算低收入和中等收入国家接受抗逆转录病毒治疗(ART)项目的人数及其覆盖范围,以及用于监测实现世界卫生组织(WHO)和联合国艾滋病规划署(UNAIDS)设定的“3年内使500万人接受治疗”目标进展情况的数据来源和方法。我们纳入了对用于估算ART项目覆盖范围的数据来源的回顾,以及为避免重复计数和过度报告所做的努力。文中描述了用于估算需要接受ART治疗人数的方法,并对儿童的治疗需求估算进行了扩展,包括ART治疗和复方新诺明预防治疗的需求。到2004年底,低收入和中等收入国家估计有650万人需要治疗,其中包括66万名15岁以下儿童。2005年年中对低收入和中等收入国家接受ART治疗人数的估计为97万(不确定范围为84万至110万),这相当于需要治疗人数的15%的覆盖率。

相似文献

引用本文的文献

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验